Recently, Yang et al. developed human serum albumin based nanoparticles for co-delivery of ibrutinib (inhibitor of Bruton’s TK) and hydroxychloroquine, and proved that the nanoparticles accumulated at the tumor site after intravenous injection and prolonged the survival in animal model of glioma [158]. The gene discussed is ALB; the disease is neoplasm.